USE OF T-CELL HYBRIDOMAS TO STUDY CUTANEOUS IMMUNOLOGY
使用 T 细胞杂交瘤研究皮肤免疫学
基本信息
- 批准号:3457209
- 负责人:
- 金额:$ 11.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-01-07 至 1995-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The research in this proposal is designed to utilize hapten specific T-cell
hybridomas to investigate the development and regulation of contact
hypersensitivity in mice. These objectives will be achieved by
investigating 1. the immune response to topically applied haptens and 2.
the effects of ultraviolet B irradiation and phorbol esters on the
immunologic functions of the skin.
We have made T-cell hybridomas that are specific for fluorescein
isothiocyanate or trinitrophenol coupled antigen presenting cells (APCs).
These hybridomas will be used to study: a. the identify of the nominal
antigens(hapten plus protein) that are responsible for the induction of
contact hypersensitivity; b. T-cell receptor gene usage in the immune
response to topically applied haptens; and c. characteristics of hapten
bearing APCs that appear in the epidermis, dermis, and other regional lymph
nodes of sensitized mice. We intend to make T-cell hybridomas in other
strains of mice (C57BL/10 and C3H.HEJ) that will allow us to study the
development of contact hypersensitivity in strains of mice that are known
to have different reactivity to contact allergens and different responses
to local UVB irradiation.
To assess the effects of UVB and phorbol myristate acetate (PMA) on the
immunologic functions of the skin, we intend to use hapten specific
hybridomas to determine whether: a. treatment of mice locally with low dose
UVB irradiation or with PMA affects the appearance and functional capacity
of APCs in the epidermis, dermis and regional lymph nodes; b. the effects
of UVB or PMA can be produced by lymphokines (eg. gamma-interferon [gamma-
IF] or tumor necrosis factor alpha [TNFalpha]) or can be blocked by
antibodies directed against lymphokines (eg. gamma-IF or TNFalpha); c.
strain differences in sensitivity to low dose, local UVB treatment; d.
hapten coupled APCs which are treated with low dose UVB in vitro are
capable of stimulating hapten-specific hybridomas; and APC function can be
restored with lymphokines (eg. IL-1) if defects in the ability of UVB
treated APCs to stimulate the hybridomas are detected. These
investigations will broaden our understanding of the role of the skin as a
component of the immune system and may have a significant impact on our
ideas about the therapy and prevention of immune mediated diseases of the
skin.
本课题的研究旨在利用半抗原特异性t细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL E BIGBY其他文献
MICHAEL E BIGBY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL E BIGBY', 18)}}的其他基金
USE OF T-CELL HYBRIDOMAS TO STUDY CUTANEOUS IMMUNOLOGY
使用 T 细胞杂交瘤研究皮肤免疫学
- 批准号:
3457208 - 财政年份:1991
- 资助金额:
$ 11.58万 - 项目类别:
T-CELL HYBRIDOMAS TO STUDY CUTANEOUS IMMUNOLOGY
T 细胞杂交瘤用于研究皮肤免疫学
- 批准号:
2079708 - 财政年份:1991
- 资助金额:
$ 11.58万 - 项目类别:
USE OF T-CELL HYBRIDOMAS TO STUDY CUTANEOUS IMMUNOLOGY
使用 T 细胞杂交瘤研究皮肤免疫学
- 批准号:
3457210 - 财政年份:1991
- 资助金额:
$ 11.58万 - 项目类别:
T-CELL HYBRIDOMAS TO STUDY CUTANEOUS IMMUNOLOGY
T 细胞杂交瘤用于研究皮肤免疫学
- 批准号:
2079709 - 财政年份:1991
- 资助金额:
$ 11.58万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 11.58万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 11.58万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 11.58万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 11.58万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 11.58万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 11.58万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 11.58万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 11.58万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 11.58万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 11.58万 - 项目类别:
Discovery Grants Program - Individual